ADVENT-HF
  • Home
  • About
  • Study details
  • Locations
  • Contact
  • Publications

​​​​​ADVENT-HF

The ADVENT-HF trial

A Multi-Centre, Randomized Study to Assess the Effects of Adaptive Servo Ventilation (ASV) on Survival and Frequency of Hospital Admissions in Patients With Heart Failure (HF) and Sleep Apnea (SA)

Sleep Apnea and Adaptive Servo Ventilation

Sleep Apnea (SA) is a disorder that causes pauses in breathing during sleep that expose the heart to oxygen deprivation. It is common in patients with heart failure (HF) where it is associated with increased risk of hospitalizations and death. It is not known however whether treating SA reduces these risks. This study is looking at whether a respiratory device known as Adaptive Servo Ventilation (ASV) can reduce the rate of cardiovascular hospitalizations and death in subjects with HF and SA. Study subjects will randomly receive either their regular medications OR their regular medications plus ASV. They will be followed for approximately 5 years and information relevant to their health will be collected and compared.

Collaborators

ClinicalTrials.gov identifier

Trial start date

Canadian Institutes of Health Research (CIHR)
Philips Respironics
NCT01128816

May 2010

Email

info@ADVENT-HF.com

Contact

​Toronto Rehabilitation Institute, University Health Network
550 University Ave, Toronto, ON, M5G 2A2
​Canada

​

  • Home
  • About
  • Study details
  • Locations
  • Contact
  • Publications